MiR-29c inhibits HCV replication via activation of type I IFN response by targeting STAT3 in JFH-1-infected Huh7 cells

Keep reading

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Extracellular Hepatitis C Virus Core Protein Activates STAT3 in Human Monocytes/Macrophages/Dendritic Cells via an IL-6 Autocrine PathwayOriginal Research · 2011 · 94 citations
2. 2Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver diseaseReview · 2016 · 12 citations